Skip to main content
Premium Trial:

Request an Annual Quote

Kenneth Berlin

Former Rosetta Genomics CEO Kenneth Berlin has been appointed president and CEO of Advaxis, effective April 23. Berlin had been president and CEO of Rosetta since 2009 before he stepped down on April 18. That firm and Genoptix have been trying to reach a deal for Genoptix's purchase of the company. Berlin previously has held executive positions at Johnson & Johnson, and J&J firms Veridex and Ortho-Clinical Diagnostics. 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.